Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes. A study in the rat
- PMID: 11407852
- DOI: 10.1177/000348940111000615
Topical ascorbic acid reduces myringosclerosis in perforated tympanic membranes. A study in the rat
Abstract
Myringosclerosis, a common finding after myringotomy, has been recently associated with an increased production of oxygen free radicals. Ascorbic acid's proposed actions include collagen synthesis, antioxidation, and free radical scavenging. The effects of topical ascorbic acid on healing tympanic membranes were studied. Particular attention was given to detecting the presence of myringosclerosis. Twelve Sprague-Dawley rats were bilaterally myringotomized. Their ears were randomized into group A, which received topical ascorbic acid in Gelfoam, group B, which received topical saline solution in Gelfoam, and group C, which received no treatment. The tympanic membranes were harvested on day 13, after routine otomicroscopy. Under light microscopy, the connective tissue layer of the untouched side of the pars tensa was distinctly thicker in group A than in group B or group C. At this level, the extent of sclerotic lesions was significantly less in the ascorbic acid-treated group. It is inferred that topical ascorbic acid reduces the occurrence of myringosclerosis following tympanic membrane perforations in the rat.
Similar articles
-
The inhibitory effect of topical N-acetylcysteine application on myringosclerosis in perforated rat tympanic membrane.Int J Pediatr Otorhinolaryngol. 2002 May 15;63(3):179-84. doi: 10.1016/s0165-5876(01)00640-1. Int J Pediatr Otorhinolaryngol. 2002. PMID: 11997152
-
The Impact of Systemic and Local Administration of Ascorbic Acid on Traumatic Perforation of Tympanic Membrane and Myringosclerosis.J Int Adv Otol. 2015 Apr;11(1):48-52. doi: 10.5152/iao.2015.193. J Int Adv Otol. 2015. PMID: 26223718
-
The impact of topical and systemic enoxaparin sodium use on traumatic tympanic membrane perforation and myringosclerosis.Eur Arch Otorhinolaryngol. 2016 Oct;273(10):3035-41. doi: 10.1007/s00405-016-3901-0. Epub 2016 Jan 21. Eur Arch Otorhinolaryngol. 2016. PMID: 26796878
-
Histologic changes of mesenchymal stem cell repair of tympanic membrane perforation.Acta Otolaryngol. 2017 Apr;137(4):411-416. doi: 10.1080/00016489.2016.1261411. Epub 2016 Dec 14. Acta Otolaryngol. 2017. PMID: 27960618 Review.
-
Ascorbic acid and fertility.Biol Reprod. 1995 Feb;52(2):262-6. doi: 10.1095/biolreprod52.2.262. Biol Reprod. 1995. PMID: 7711198 Review.
Cited by
-
Effect of Topical Dexamethasone for Preventing Experimentally Induced Myringosclerosis.Turk Arch Otorhinolaryngol. 2017 Mar;55(1):3-9. doi: 10.5152/tao.2017.2077. Epub 2017 Mar 1. Turk Arch Otorhinolaryngol. 2017. PMID: 29392044 Free PMC article.
-
Is there any effect of montelukast on prevention of myringosclerosis after myringotomy in a rat model?Eur Arch Otorhinolaryngol. 2019 Jan;276(1):57-62. doi: 10.1007/s00405-018-5181-3. Epub 2018 Oct 30. Eur Arch Otorhinolaryngol. 2019. PMID: 30377759
-
The Short-Term Effect of Eugenol on the Prevention of Experimentally Induced Myringosclerosis in a Rat Model.Turk Arch Otorhinolaryngol. 2021 Jun;59(2):124-132. doi: 10.4274/tao.2021.6196. Epub 2021 Jul 30. Turk Arch Otorhinolaryngol. 2021. PMID: 34386799 Free PMC article.
-
Do all antioxidant supplements have the same potential effect on preventing myringosclerosis?Clin Exp Otorhinolaryngol. 2015 Mar;8(1):1-6. doi: 10.3342/ceo.2015.8.1.1. Epub 2015 Feb 3. Clin Exp Otorhinolaryngol. 2015. PMID: 25729488 Free PMC article.
-
Evaluation of the effectiveness of topical ciprofloxacin and prednisolone in the prevention of myringosclerosis.Eur Arch Otorhinolaryngol. 2012 Nov;269(11):2335-41. doi: 10.1007/s00405-011-1889-z. Epub 2011 Dec 25. Eur Arch Otorhinolaryngol. 2012. PMID: 22197890
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous